We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · January 02, 2020

IOP After Intravitreal Dexamethasone Implant Among Different Geographic Populations

Eye (London, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Eye (London, England)
Intraocular Pressure (IOP) After Intravitreal Dexamethasone Implant (Ozurdex) Amongst Different Geographic Populations—GEODEX-IOP Study
Eye (Lond) 2019 Sep 30;[EPub Ahead of Print], A Sharma, BD Kuppermann, F Bandello, P Lanzetta, D Zur, SW Park, HG Yu, VR Saravanan, LC Zacharias, AK Barreira, M Iglicki, F Miassi, D Veritti, S Tsao, D Makam, N Jain, A Loewenstein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading